Diet Can Reduce Risk Of Breast Cancer
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Diet Can Reduce Risk Of Breast Cancer

LONDON, ENGLAND -- October 3, 1997 – In The Lancet this week, Dr. David Ingram and colleagues from Perth, Australia, show there is a substantial reduction in breast-cancer risk among women with a high intake of phyto-estrogens -- particularly the isoflavonic phyto-estrogen equol and the lignan enterolactone.

Phyto-estrogens are naturally-occurring chemicals derived from plants and form part of our diet. They are found predominantly in soya products and in the fibre present in whole grains, berries, fruit, vegetables and flax seed. The structure of phyto-estrogens are similar to the female hormone, estrogen.

The researchers interviewed women with newly-diagnosed breast cancer and took urine and blood samples before any treatment started. Controls were randomly selected from the electoral role after matching for age and area of residence. One hundred and forty-four pairs were included for analysis. The urine samples were tested for the isoflavonic phyto-estrogens daidzen, genistein and equol and the lignans enterodiol, enterolactone and matairesinol.

After adjustment for age at first menstrual period, parity (number of live births) and alcohol and total-fat intakes, high excretion of both equol and enterolactone was associated with a substantial reduction in breast-cancer risk. There was a reduction in risk for most other phyto-estrogens, but it did not reach significance. Difficulties with the genistein assay precluded analysis of that substance.

"This finding supports previous observational studies that reported higher phyto-estrogen excretion among populations with a low frequency of breast cancer," the researchers write.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities